Watanabe J et al. |
Safety Evaluation of Trastuzumab Emtansine in Japanese Patients with HER2-Positive Advanced Breast Cancer. |
|
In Vivo |
pmid:28438884
|
Yardley DA et al. |
Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Metastatic Breast Cancer Previously Treated With Chemotherapy and 2 or More HER2-Targeted Agents: Results From the T-PAS Expanded Access Study. |
|
Cancer J |
pmid:26389758
|
Muzaffar M et al. |
Acute Pancreatitis Associated With Ado-Trastuzumab Emtansine. |
|
Am J Ther |
pmid:25756468
|
|
|
|
|
pmid:
|
Hanka LJ and Barnett MS |
Microbiological assays and bioautography of maytansine and its homologues. |
1974 |
Antimicrob. Agents Chemother. |
pmid:15825322
|
Mandelbaum-Shavit F et al. |
Binding of maytansine to rat brain tubulin. |
1976 |
Biochem. Biophys. Res. Commun. |
pmid:985482
|
Sieber SM et al. |
Pharmacology of antitumor agents from higher plants. |
1976 |
Cancer Treat Rep |
pmid:136296
|
Mugera GM and Ward JM |
Acute toxicity of maytansine in F344 rats. |
1977 |
Cancer Treat Rep |
pmid:563288
|
Bhattacharyya B and Wolff J |
Maytansine binding to the vinblastine sites of tubulin. |
1977 |
FEBS Lett. |
pmid:852577
|
Kupchan SM et al. |
The maytansinoids. Isolation, structural elucidation, and chemical interrelation of novel ansa macrolides. |
1977 |
J. Org. Chem. |
pmid:874612
|
Hull RN et al. |
Studies on tissue culture produced plasminogen activator. I. Preliminary observations and the enhancing effect of colchicine and other antimitotic agents. |
1977 |
Thromb. Res. |
pmid:18812
|
Wehrli W |
Ansamycins. Chemistry, biosynthesis and biological activity. |
1977 |
Top Curr Chem |
pmid:74108
|
Osieka R et al. |
Chemotherapy of human colon cancer xenografts in athymic nude mice. |
1977 |
Cancer |
pmid:144557
|
Wall ME and Wani MC |
Antineoplastic agents from plants. |
1977 |
Annu. Rev. Pharmacol. Toxicol. |
pmid:326159
|
Higashide E et al. |
Ansamitocin, a group of novel maytansinoid antibiotics with antitumour properties from Nocardia. |
1977 Dec 22-29 |
Nature |
pmid:593392
|
O'Connell MJ et al. |
Phase II trial of maytansine in patients with advanced colorectal carcinoma. |
1978 |
Cancer Treat Rep |
pmid:356981
|
Issell BF and Crooke ST |
Maytansine. |
1978 |
Cancer Treat. Rev. |
pmid:367597
|
Kupchan SM et al. |
Structural requirements for antileukemic activity among the naturally occurring and semisynthetic maytansinoids. |
1978 |
J. Med. Chem. |
pmid:563462
|
Sieber SM et al. |
Teratogenic and cytogenetic effects of some plant-derived antitumor agents (vincristine, colchicine, maytansine, VP-16-213 and VM-26) in mice. |
1978 |
Teratology |
pmid:694777
|
Johnson RK et al. |
Stathmokinetic and therapeutic effects of maytansine in mice bearing P388 and L1210 leukemias. |
1978 |
Biochem. Pharmacol. |
pmid:708479
|
Eagan RT et al. |
Phase II evaluation of maytansine in patients with metastatic lung cancer. |
1978 |
Cancer Treat Rep |
pmid:709559
|
Alabaster O and Cassidy M |
Flow microfluorometric analysis of P388 murine leukemia after administration of vincristine and maytansine in vivo. |
1978 |
J. Natl. Cancer Inst. |
pmid:625068
|
Eagan RT et al. |
Early clinical study of an intermittent schedule for maytansine (NSC-153858): brief communication. |
1978 |
J. Natl. Cancer Inst. |
pmid:628025
|
Cabanillas F et al. |
Phase I study of maytansine using a 3-day schedule. |
1978 |
Cancer Treat Rep |
pmid:348310
|
Chabner BA et al. |
Initial clinical trials of maytansine, an antitumor plant alkaloid. |
1978 |
Cancer Treat Rep |
pmid:348311
|
Blum RH and Kahlert T |
Maytansine: a phase I study of an ansa macrolide with antitumor activity. |
1978 |
Cancer Treat Rep |
pmid:348312
|
Blum RH et al. |
A therapeutic trial of maytansine. |
1978 |
Cancer Clin Trials |
pmid:757139
|
Douros J and Suffness M |
New natural products of interest under development at the National Cancer Institute. |
1978 |
Cancer Chemother. Pharmacol. |
pmid:86390
|
Donoso JA et al. |
Maytansine action on fast axoplasmic transport and the ultrastructure of vagal axons. |
1978 |
Cancer Res. |
pmid:77186
|
Carter SK |
New drugs under clinical evaluation in the United States. |
1978 |
Cancer Chemother. Pharmacol. |
pmid:155503
|
Tanida S et al. |
Inhibition of cilia regeneration of Tetrahymena by ansamitocins, new antitumor antibiotics. |
1979 |
Antimicrob. Agents Chemother. |
pmid:475367
|
Rao PN et al. |
Cell cycle phase-specific cytotoxicity of the antitumor agent maytansine. |
1979 |
Cancer Res. |
pmid:455300
|
Cabanillas F et al. |
Results of a phase II study of maytansine in patients with breast carcinoma and melanoma. |
1979 |
Cancer Treat Rep |
pmid:371803
|
Ghetti B |
Induction of neurofibrillary degeneration following treatment with maytansine in vivo. |
1979 |
Brain Res. |
pmid:581857
|
Maslin DN |
[Ansamycins]. |
1979 |
Antibiotiki |
pmid:37801
|
Aldrich CD |
Pleiotropic phenotype of cultured murine cells resistant to maytansine, vincristine, colchicine, and adriamycin. |
1979 |
J. Natl. Cancer Inst. |
pmid:224236
|
Chahinian AP et al. |
Phase I study of weekly maytansine given by iv bolus or 24-hour infusion. |
1979 Nov-Dec |
Cancer Treat Rep |
pmid:526928
|
Creagan ET et al. |
Phase II evaluation of maytansine in patients with advanced head and neck cancer. |
1979 Nov-Dec |
Cancer Treat Rep |
pmid:526939
|
Oki T |
Cytotoxic and antitumor antibiotics produced by microorganisms. |
1980 |
Biotechnol. Bioeng. |
pmid:6159010
|
Ootsu K et al. |
Effects of new antimitotic antibiotics, ansamitocins, on the growth of murine tumors in vivo and on the assembly of microtubules in vitro. |
1980 |
Cancer Res. |
pmid:6245801
|
Tanida S et al. |
Ansamitocin-induced synchrony in Tetrahymena pyriformis. |
1980 |
J. Gen. Microbiol. |
pmid:6777454
|
Franklin R et al. |
A phase I-II study of maytansine utilizing a weekly schedule. |
1980 |
Cancer |
pmid:7214295
|
Jaffrey IS et al. |
Response to maytansine in a patient with malignant thymoma. |
1980 |
Cancer Treat Rep |
pmid:7379057
|
Tanida S et al. |
Ansamitocins, maytansinoid antitumor antibiotics. Producing organism, fermentation, and antimicrobial activities. |
1980 |
J. Antibiot. |
pmid:7380728
|
Kim SU et al. |
Neurofibrillary degeneration in cultured adult mouse neurons induced by maytansine. |
1980 |
Acta Neuropathol. |
pmid:7435167
|
Friedkin M and Rozengurt E |
The role of cytoplasmic microtubules in the regulation of the activity of peptide growth factors. |
1980 |
Adv. Enzyme Regul. |
pmid:7039258
|
Neidhart JA et al. |
Minimal single-agent activity of maytansine in refractory breast cancer: a Southwest Oncology Group study. |
1980 Apr-May |
Cancer Treat Rep |
pmid:7427953
|
Ahmann DL et al. |
Phase II study of maytansine and chlorozotocin in patients with disseminated malignant melanoma. |
1980 Apr-May |
Cancer Treat Rep |
pmid:6448689
|
Rosenthal S et al. |
Phase II study of maytansine in patients with advanced lymphomas: an Eastern Cooperative Oncology Group pilot study. |
1980 Oct-Nov |
Cancer Treat Rep |
pmid:7459897
|
Lin CM and Hamel E |
Effects of inhibitors of tubulin polymerization on GTP hydrolysis. |
1981 |
J. Biol. Chem. |
pmid:6114958
|
Schrek R and Stefani SS |
Toxicity of microtubular drugs to leukemic lymphocytes. |
1981 |
Exp. Mol. Pathol. |
pmid:7238845
|
Stebbings H and van Bueren J |
Stability of microtubules from insect ovarioles. |
1981 |
Cell Biol. Int. Rep. |
pmid:7273149
|
Tanida S et al. |
Ansamitocin analogs from a mutant strain of Nocardia. I. Isolation of the mutant, fermentation and antimicrobial properties. |
1981 |
J. Antibiot. |
pmid:7275830
|
Izawa M et al. |
Ansamitocin analogs from a mutant strain of Nocardia. II. Isolation and structure. |
1981 |
J. Antibiot. |
pmid:7275831
|
Luduena RF and Roach MC |
Contrasting effects of maytansine and vinblastine on the alkylation of tubulin sulfhydryls. |
1981 |
Arch. Biochem. Biophys. |
pmid:7305339
|
Schatten G and Schatten H |
Effects of motility inhibitors during sea urchin fertilization: microfilament inhibitors prevent sperm incorporation and restructuring of fertilized egg cortex, whereas microtubule inhibitors prevent pronuclear migrations. |
1981 |
Exp. Cell Res. |
pmid:7308293
|
York J et al. |
Binding of maytansinoids to tubulin. |
1981 |
Biochem. Pharmacol. |
pmid:7317106
|
Wang XF et al. |
[Studies on the antitumor constituents of Maytenus confertiflora Luo et Chen (Celastraceae). II. Isolation and characterization of maytansine and maytanprine from the stems]. |
1981 |
Yao Xue Xue Bao |
pmid:7324964
|
Lin CM et al. |
Binding of maytansine to tubulin: competition with other mitotic inhibitors. |
1981 |
Res. Commun. Chem. Pathol. Pharmacol. |
pmid:7255878
|
Nakahama K et al. |
Microbial conversion of ansamitocin. |
1981 |
J. Antibiot. |
pmid:7333971
|
Izawa M et al. |
Demethylation of ansamitocins and related compounds. |
1981 |
J. Antibiot. |
pmid:7333972
|
Izawa M et al. |
Hydroxylation of ansamitocin P-3. |
1981 |
J. Antibiot. |
pmid:7333973
|
Baskin F et al. |
Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. |
1981 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:6943568
|
Ikeyama S and Takeuchi M |
Antitubulin activities of ansamitocins and maytansinoids. |
1981 |
Biochem. Pharmacol. |
pmid:21043240
|
Edmonson JH et al. |
Phase II study of maytansine in advanced breast cancer. |
1981 May-Jun |
Cancer Treat Rep |
pmid:7237478
|
Ono Y et al. |
Antitumor and cytocidal activities of a newly isolated benzenoid ansamycin, macbecin I. |
1982 |
Gan |
pmid:6186564
|
Creech RH et al. |
Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578). |
1982 |
Cancer Treat Rep |
pmid:6282460
|
Ratanatharathorn V et al. |
Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study. |
1982 |
Cancer Treat Rep |
pmid:7093975
|
Hatano K et al. |
Biosynthetic origin of aminobenzenoid nucleus (C7N-unit) of ansamitocin, a group of novel maytansinoid antibiotics. |
1982 |
J. Antibiot. |
pmid:7174527
|
Borden EC et al. |
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomas. |
1982 |
Am. J. Clin. Oncol. |
pmid:6956236
|
Slavik M et al. |
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience. |
1982 |
Am. J. Clin. Oncol. |
pmid:6897490
|
Perdue RE |
KB cell culture I. Role in discovery of antitumor agents from higher plants. |
1982 Jul-Aug |
J. Nat. Prod. |
pmid:7130986
|
deVere White R et al. |
Maytansine as a cause of acute proliferative disorder of bladder urothelium in the rat. |
1983 |
Cancer Treat Rep |
pmid:6825127
|
Thigpen JT et al. |
Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary. A Gynecologic Oncology Group study. |
1983 |
Am. J. Clin. Oncol. |
pmid:6846245
|
Edmonson JH et al. |
Phase II study of maytansine in advanced sarcomas. |
1983 |
Cancer Treat Rep |
pmid:6850657
|
Thigpen JT et al. |
Phase II study of maytansine in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. |
1983 |
Am. J. Clin. Oncol. |
pmid:6869315
|
Ghetti B and Gambetti P |
Comparative immunocytochemical characterization of neurofibrillary tangles in experimental maytansine and aluminum encephalopathies. |
1983 |
Brain Res. |
pmid:6354362
|
Fan YJ et al. |
[Use of 1,2:5,6-dianhydrogalactitol in combination with maytansine in experimental tumor therapy]. |
1983 |
Yao Xue Xue Bao |
pmid:6677049
|
Sabio H et al. |
Maytansine in refractory childhood acute lymphocytic leukemia: a Pediatric Oncology Group study. |
1983 |
Cancer Treat Rep |
pmid:6580069
|
Tsuruo T et al. |
Establishment and properties of vincristine-resistant human myelogenous leukemia K562. |
1983 |
Gan |
pmid:6580255
|
Akimoto H et al. |
Chemical modification of ansamitocins. II. Synthesis of 3-epimaytansionoids via 3-maytansinones. |
1984 |
Chem. Pharm. Bull. |
pmid:6437689
|
Kawai A et al. |
Chemical modification of ansamitocins. III. Synthesis and biological effects of 3-acyl esters of maytansinol. |
1984 |
Chem. Pharm. Bull. |
pmid:6441645
|
Rebert CS et al. |
Effects of vincristine, maytansine, and cis-platinum on behavioral and electrophysiological indices of neurotoxicity in the rat. |
1984 |
J Appl Toxicol |
pmid:6542922
|
Roach MC and Ludueña RF |
Different effects of tubulin ligands on the intrachain cross-linking of beta 1-tubulin. |
1984 |
J. Biol. Chem. |
pmid:6480599
|
Niell HB et al. |
Effect of concentration and time of drug exposure on clonal growth of murine bladder cancer. |
1985 |
Urology |
pmid:2579500
|
|
Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas. Gastrointestinal Tumor Study Group. |
1985 |
Cancer Treat Rep |
pmid:2859924
|
Fan YJ et al. |
[Effect of maytansine on the cell cycle of Ehrlich ascites carcinoma cells in mice]. |
1985 |
Zhongguo Yao Li Xue Bao |
pmid:3158164
|
Ravry MJ et al. |
Phase II evaluation of maytansine (NSC 153858) in advanced cancer. A Southeastern Cancer Study Group trial. |
1985 |
Am. J. Clin. Oncol. |
pmid:3834790
|
Gupta RS |
Species-specific differences in toxicity of antimitotic agents toward cultured mammalian cells. |
1985 |
J. Natl. Cancer Inst. |
pmid:3855475
|
Fellous A et al. |
Effects of Tau and MAP2 on the interaction of maytansine with tubulin: inhibitory effect of maytansine on vinblastine-induced aggregation of tubulin. |
1985 |
Cancer Res. |
pmid:3928146
|
Banerjee A et al. |
Interaction of reduced glutathione with bovine brain tubulin. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3994709
|
Huang AB et al. |
Maytansine inhibits nucleotide binding at the exchangeable site of tubulin. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:4004859
|
Sato Y et al. |
Induction of neurofibrillary tangles in cultured mouse neurons by maytanprine. |
1985 |
J. Neurol. Sci. |
pmid:4040155
|
Luduena RF et al. |
N,N'-Ethylene-bis(iodoacetamide) as a probe for structural and functional characteristics of brine shrimp, squid, and bovine tubulins. |
1985 |
Can. J. Biochem. Cell Biol. |
pmid:4041960
|
Schibler MJ and Cabral FR |
Maytansine-resistant mutants of Chinese hamster ovary cells with an alteration in alpha-tubulin. |
1985 |
Can. J. Biochem. Cell Biol. |
pmid:4041962
|
Duanmu C et al. |
Tubulin polymerization with ATP is mediated through the exchangeable GTP site. |
1986 |
Biochim. Biophys. Acta |
pmid:3004597
|
Tsuruo T et al. |
Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines. |
1986 |
Cancer Res. |
pmid:3753552
|
Luduena RF et al. |
Interactions of vinblastine and maytansine with tubulin. |
1986 |
Ann. N. Y. Acad. Sci. |
pmid:3460446
|
Takahashi M et al. |
Rhizoxin binding to tubulin at the maytansine-binding site. |
1987 |
Biochim. Biophys. Acta |
pmid:3120782
|
Lacey E et al. |
Interaction of phomopsin A and related compounds with purified sheep brain tubulin. |
1987 |
Biochem. Pharmacol. |
pmid:3606630
|